Etomav 90 Tablet contains Etoricoxib 90mg, a selective COX-2 inhibitor used primarily for the management of pain and inflammation associated with various musculoskeletal and joint disorders. It is commonly prescribed for conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. By selectively inhibiting the cyclooxygenase-2 enzyme, Etoricoxib reduces the production of prostaglandins responsible for pain and inflammation, offering effective relief with a lower risk of gastrointestinal side effects compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs). Etomav 90 is typically administered once daily, with or without food, based on the severity of symptoms and physician recommendations. Patients are advised to use this medication at the lowest effective dose for the shortest duration necessary to minimize potential cardiovascular and renal risks. It is contraindicated in individuals with known hypersensitivity to Etoricoxib, active peptic ulcers, severe heart failure, or those with a history of allergic reactions to NSAIDs. Common side effects may include headache, dizziness, hypertension, and gastrointestinal discomfort. Before starting Etomav 90, patients should inform their healthcare provider about any existing medical conditions or concurrent medications to avoid adverse interactions and ensure safe use.